martino introna
机构: Qualified Person, Centro di Terapia Cellulare "G. Lanzani" ASST Papa Giovanni XXIII Bergamo Italy
每年引用次数
引用次数
引用: 21,862
H-指数: 78
I10-指数 : 199
出版物: 442
The human A-myb protein is a strong activator of transcription.
J Golay , Mario Luppi , M. Introna , L Loffarelli
Oncogene 9 ( 9) 2469 -2479
47
1994
Treatment of murine peritoneal macrophages with bacterial lipopolysaccharide alters expression of c-fos and c-myc oncogenes.
R. C. Bast , R. E. Kaufman , D. O. Adams , Thomas A Hamilton
Journal of Immunology 137 ( 8) 2711 -2715
77
1986
The effect of LPS on expression of the early "competence" genes JE and KC in murine peritoneal macrophages.
C. S. Tannenbaum , Robert C Bast , D. O. Adams , T. A. Hamilton
Journal of Immunology 138 ( 11) 3891 -3896
115
1987
Gene transfer-mediated expression of physiological numbers of the type II decoy receptor in a myelomonocytic cellular context dampens the response to interleukin-1
N. Polentarutti , M. Introna , M. Sironi , A. Mantovani
European Cytokine Network 8 ( 3) 265 -269
13
1997
Inhibition of monocyte chemotaxis to c-c chemokines by antisense oligonucleotide for cytosolic phospholipase A2 (cPLA2)
A. Mantovani , S. Sozzani , G. Lamorte , S. Bernasconi
The FASEB Journal 10 ( 6)
5
1996
In vitro migration of human large granular lymphocytes (LGL)
B. Bottazzi , M. Introna , P. Allavena
Federation Proceedings 43 ( 6)
1984
STUDIO DELL'ATTIVITA N.K. IN UN GRUPPO DI TOSSICODIPENDENTI CON LINFOADENOPATIA GENERALIZZATA
A. Lazzarin , M. Introna , F. Zanaboni , M. Galli
Giornale di malattie infettive e parassitarie 37 ( 6) 455 -457
1985
Gene expression profile and signaling induced by rituximab in human B lymphoma cell lines.
G Cartron , L Zelante , E Cittera , P Paolucci
Blood 102
2003
Immunomonitoring of Transplanted Patients Infused With Mesenchymal Stromal Cells (MSC) for Treating Steroid-Refractory GVHD
E. Dander , G. Lucchini , P. Vinci , M. Introna
Biology of Blood and Marrow Transplantation 17 ( 2)
1
2011
Platelet-Lysate-Expanded Mesenchymal Stromal Cells for the Treatment of Resistant GVHD
G. Lucchini , E. Dander , A. Rovelli , A. Balduzzi
Biology of Blood and Marrow Transplantation 17 ( 2)
2011
Frequent occurrence of non-malignant genetic alterations in clinical grade mesenchymal stromal cells expanded for cell therapy protocols
C. Capelli , O. Pedrini , G. Cassina , O. Spinelli
Haematologica 99 ( 6)
19
2014
Ibrutinib interferes with the cell-mediated anti-tumor activities of therapeutic CD20 antibodies: implications for combination therapy
F. D. Roit , P. J. Engelberts , R. P. Taylor , E. C. W. Breij
Haematologica 100 ( 1) 77 -86
111
2015
Migratory Response of Human NK Cells to Monocyte-Chemotactic Proteins☆
P. Allavena , G. Bianchi , P. Giardina , N. Polentarutti
Methods 10 ( 1) 145 -149
16
1996
Individualized administration of capecitabine plus lapatinib in heavily pretreated HER2+ metastatic breast cancer patients: A single-center experience.
P. Papaldo , G. Metro , A. Felici , M. Russillo
Journal of Clinical Oncology 28 1108 -1108
2010
Endothelial cell regulation of leukocyte infiltration in inflammatory tissues.
A. Duperray , A. Mantovani , M. Introna , E. Dejana
Mediators of Inflammation 4 ( 5) 322 -330
23
1995
CIK as therapeutic agents against tumors.
M. Introna
Journal of Autoimmunity 85 32 -44
20
2017
PF435 A FLEXIBLE THERAPEUTIC STRATEGY FOR LEUKEMIA USING EX-VIVO EXPANDED T CELLS COMBINED WITH BISPECIFIC ANTIBODIES
J. Golay , E. Gotti , A. Interdonato , R. Valgardsdottir
HemaSphere 3 ( S1) 170 -171
2019
PF436 GMP MANUFACTURING OF ALLOGENEIC CD19 CHIMERIC ANTIGEN RECEPTOR (CAR) CYTOKINE INDUCED KILLER (CIK) CELLS WITH SLEEPING BEAUTY (SB) TRANSPOSON FOR ADOPTIVE IMMUNOTHERAPY
C.F. Magnani , G. Gaipa , D. Belotti , G. Matera
HemaSphere 3 ( S1) 171
2019
Outbreak of Persistent, Unexplained, Generalized Lymphadenopathy With Immunological Abnormalities in Drug Addicts in Milan
A. Lazzarin , M. Galli , Cristina Negri , M. Moroni
Infection 12 ( 6) 372 -376
10
1984
Impairement of human NK activity by cyclosporin A
M. Introna , P. Allavena , F. Spreafico , A. Mantovani
International Journal of Immunopharmacology 2 ( 3) 219
1980